Is Teladoc undervalued?

The revenue per member was reported $2.32 in 2021, up from $1.12 in 2020. I believe Teladoc's stock price is undervalued based on relative valuation indicators. The stock's price-to-sales ratio hit below 4 in mid-March (lowest since 2016) and is trading at 5.33, while the price-to-book ratio is at 0.69.

Is Teladoc overvalued?

Valuation metrics show that Teladoc Health, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of TDOC, demonstrate its potential to underperform the market.

Will Teladoc ever be profitable?

The telehealth giant isn't yet profitable and reported a loss of $84.3 million in the third quarter of 2021, deeper than its year-prior loss of $36 million. Shares of Teladoc stock fell 6.2% on Monday as of 10:47 a.m. in New York.

Is there a future for Teladoc?

In 2021, Teladoc's revenue grew by 86% year over year (YOY) to roughly $2 billion. That's impressive, considering how active the company was in 2020. Teladoc's total visits in 2021 increased by 38% YOY to 15.4 million.

Is Teladoc worth investing in?

Teladoc Health, Inc. (NYSE:TDOC) delivered a -39.02% return since the beginning of the year, while its 12-month returns are down by -67.23%. The stock closed at $55.99 per share on April 25, 2022. "Teladoc is the largest telehealth provider in the US and has recently begun to expand internationally.

Is Teladoc UNDERVALUED? | (TDOC) Stock Analysis

Why is Teladoc dropping?

The jaw-dropping loss came from an impairment charge of over $6.5 billion. Teladoc also cut its full-year outlook, saying factors like higher advertising costs in the mental health market are resulting in lower yields.

Why has Teladoc crashed?

Teladoc stock fell in after-hours trading Tuesday after the telehealth giant posted fourth-quarter earnings, despite results exceeding Wall Street's expectations on profit and revenue.

Will Teladoc ever recover?

Despite the stock's steady decline over the past year, Teladoc Health still holds a promising future due to its disruptive model. According to Tulane University School of Public Health and Tropical Medicine, Telemedicine is here to stay for the foreseeable future.

Is Pinterest a buy Zacks?

Zacks' proprietary data indicates that Pinterest, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the PINS shares relative to the market in the next few months.

Is Roku a buy?

The bottom line for investors

Roku's price-to-sales ratio is currently 4.5, which is approximately the same as at the beginning of 2019. This means the company is essentially as expensive as it was then when it had only 27 million active accounts, 7.3 billion total streaming hours, and an ARPU of $17.95.

What do analysts say about teladoc?

Teladoc Health Inc (NYSE:TDOC)

The 24 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 43.50, with a high estimate of 141.00 and a low estimate of 30.00. The median estimate represents a +21.61% increase from the last price of 35.77.

Who are teladoc competitors?

Teladoc Health's top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.

What is teladoc PE ratio?

Teladoc Health's p/e ratio (fwd) is -24.9x. Teladoc Health's p/e ratio (fwd) is expected to average -71.4x over the next five fiscal years.

What was teladoc IPO price?

Telehealth platform company Teladoc, on Tuesday, announced that its initial public offering would be priced at $19 per share, raising $157 million, according to a Renaissance Capital post to NASDAQ.com.

Did Cathie sell Teladoc?

Unfortunately for Cathie Wood, Ark Invest is heavily invested into Teladoc. The exchange-traded fund (ETF) manager reported purchasing the company twice this week, on both Monday and Tuesday. On Monday, Ark ETFs reported purchasing 44,940 shares. The next day, Ark ETFs purchased 101,563 shares.

Who is buying Teladoc?

Wood again purchased about 610,000 Teladoc shares via four ARK exchange-traded funds on Thursday, with most of the buying by its flagship ARK Innovation ETF, according to its daily trading update. The company is part of a group of former pandemic winners backed by Wood.

How much has Cathie Woods lost?

Cathie Wood's ARKK falls 60% from its peak, erasing all post-pandemic gains.

Is Teladoc an acquisition target?

As a reader, you need to bear in mind that Teladoc is an acquisition vehicle; we thus need to consider that its "struggle towards profitability" has been down to transitory costs rather than a flawed business model.

Is Teladoc a big company?

Teladoc (NYSE: TDOC) is one of the largest companies in the telemedicine space, expanding its reach with the acquisition of Livongo in 2020. Teladoc forecasts revenue growth of between $367 million to $467 million by the end of 2022 with total visits expected to rise between 20% and 27% from 15.4 million a year ago.

Which telemedicine company is best?

How does Teladoc make money?

How does Teladoc Make Money? Teladoc's major revenue source is from the subscription-based model. Patients pay annual or monthly fees for consultation. The subscription-based plan starts from $49, they also sell services to clients on behalf of their employees.

Is Roku being shorted?

Short Shares Availability

This table shows the number of shares of US:ROKU available to be shorted at a leading prime brokerage.

What is the prediction for Roku stock?

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for Roku Inc have a median target of 159.00, with a high estimate of 240.00 and a low estimate of 80.00. The median estimate represents a +82.67% increase from the last price of 87.04.

Is Tesla a buy?

Tesla stock has had a tough 2022, but now UBS has upgraded shares to Buy from Neutral while keeping its price target unchanged at $1,100.